Boost cancer prevention and survival through Asian nutritional diet

September 6, 2022 Providence Cancer Institute of Oregon

Share this Article
Facebook
Twitter
Email
LinkedIn

Providence registered dietitian Grace Laman, MS, RDN, CSO, explains how to decide the best diet before, during and after cancer treatment. She also shares the most current research on cancer prevention and diet and helps you understand the right supplements to use.

This educational talk is presented by Providence Cancer Institute and the Asian Health and Service Center.

About the presenter

Grace Laman, MS, RDN, CSO, is a clinical dietitian at Providence. She provides nutrition guidance and counseling to help support the needs of patients before, during and after cancer treatment. Grace has spent her career counseling patients with a variety of clinical conditions, most recently focusing on supporting the nutrition needs of cancer patients.

Learn more about nutrition counseling at Providence.

Earle A. Chiles Research Institute scientist awarded K22 to develop new lab

Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discove...

Providence Cancer Institute to cohost Oregon neuroendocrine tumor conference

Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gath...

Other content in this Stream

Learn how integrative medicine can improve quality of life for cancer patients

Boost cancer prevention and survival through Asian nutritional diet

About the presenter

Previous Article

Next Article

Other content in this Stream

Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.

Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.

Ion robot-assisted bronchoscopy platform is first of its kind in South Puget Sound

Caregivers and providers are invited to join State of Science Summit: Lung Cancer in downtown Portland. Topics include new cancer treatment approaches, research and strategies.

James Bredenkamp, MD, a dedicated head and neck surgeon and skilled health care leader, has been named executive medical director of the Leonard Cancer Institute at Providence Mission Hospital.

Providence is partnering with Stand Up To Cancer on a multi-year effort called the CHAT project focused on increasing colorectal cancer screenings in communities of color.

Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.

Rates of colorectal cancer are rising, particularly among Black, Brown and Indigenous young men. Learn how Providence and SU2C are tackling this challenge.

As a retired nurse and current fitness instructor, Lorraine Clarke is a health advocate for everyone in her life. Sometimes though, it is easy to forget about one’s own healthy practices.

Leading lung cancer professionals to gather in November for premier oncology summit.

New studies co-authored by Providence Research Network Researchers help identify drug resistance and reversal mechanisms in breast cancer

Providence gynecologic oncologist Christopher Darus, M.D. shares the latest research and promising treatments for gynecologic cancers.

Please join us for a series of events and activities throughout October

It’s Gynecologic Cancer Awareness Month, so take the time to learn more about ovarian, endometrial/uterine, vulvar and vaginal cancer prevention.

Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.

New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.

Providence Cancer Institute experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a virtual symposium.

Providence Little Company of Mary Medical Centers earn US News rankings, rated among top hospitals in California

New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer

Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.